Medtronic has released its Touch Surgery Live Stream digital offering with 14 new algorithms for AI surgical insights in robotic-assisted and laparoscopic surgeries. The offering is designed to offer an immersive virtual learning environment through live streams of procedures.
Bruker has agreed to acquire most of Nanostring's assets for approximately $392.6 million in cash. The transaction is expected to help strengthen Bruker's position in spatial technology-based disease treatment and diagnosis.
Innosuisse and InnovateUK have given machineMD and gaitQ a $1 million grant to support an 18-month study involving patients with Parkinson's disease. The study data will be used to allow early disease detection and treatment, find more effective treatment plans and identify behavior patterns.
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator has given Scout $1 million for the development of the STI Scout assay. The point-of-care molecular diagnostic test runs on the company's isothermal molecular diagnostic system to detect and differentiate Neisseria gonorrhoeae and Chlamydia trachomatis.
A study in JCI Insight found that an experimental at-home urine test that tracks tiny DNA fragments from tumors may aid in the early detection of head and neck cancers. The test may also be adjusted to spot the DNA fragments from other cancers, such as breast cancer and leukemia, according to researchers.
PET/MRI scans indicate increased brain metabolism in young women with autism spectrum disorder that is linked to translocator protein, researchers reported in Neuropsychopharmacology. The findings also showed elevated uptake of C-11 PBR28 radiotracer in specific brain regions, underscoring the need for further investigation into sex-based differences in ASD neurobiology.
GE HealthCare has unveiled the Voluson Signature 20 and 18 ultrasound systems. The artificial intelligence-enhanced systems are designed for imaging applications on conditions affecting women's health.
Center for Devices and Radiological Health Director Jeff Shuren said the FDA is looking into reforming the premarket review program for medical devices and diagnostics to allow more flexibility, reduce deficiency letters and streamline the review process. "Where we'd like to be is we have no or very few deficiencies, high-quality submissions, and we finished our review in one cycle. That really should be our shared objective at the end of the day," said Shuren.
The FDA has granted approval to the LumiSystem breast cancer direct visualization system from Lumicell. The system demonstrates 84% diagnostic accuracy in detecting and resecting residual cancer during post-lumpectomy scanning of the breast cavity.
The Drug Master File submitted by X-Therma for its XT-Thrive cryopreservation system has been accepted by the FDA. The system is developed for the cryopreservation of organs and drugs that are used in manufacturing products such as vaccines, monoclonal antibodies and fusion and recombinant proteins.
Registration is open for AdvaMed's 101 Workshop: MedTech Coverage, Coding and Reimbursement! Our 101 program will discuss the "three-legged stool" of payment--coding, coverage, and reimbursement--as well as reviewing market access opportunities for novel technologies through both existing Medicare payment pathways and proposals to streamline Medicare policies in the future. Register for this virtual event to gain a comprehensive understanding of the basic principles of how medical technologies are covered and paid by insurers, the challenges medtech companies face and strategies they can use to achieve positive outcomes for coverage and appropriate reimbursement. Visit our website to view the Workshop agenda. Learn more.
Registration is open for the Payment Policy Forum happening in AdvaMed's Washington, D.C. office, May 21-22, 2024! This Forum is designed for experienced medtech professionals that have a deep understanding of the evolving landscape of payment policies. Join leaders from CMS, industry, and academia as they discuss payment for digital health technologies, private payer challenges, new CMS policies and more. This Forum will provide attendees with actionable strategies for achieving successful payment outcomes for their organization. Network with your fellow peers and get tips on how to navigate working with CMS during this two-day event. Visit our website to view the preliminary agenda. Learn more.
.png)
